Prime Medicine Inc.

PRME | NASDAQ

Price Alert Chart Builder DCF Calculator

$3.19

+$0.07 (+2.24%)

At close: Sep 21, 2026, 4:00 PM ET

$3.22

+$0.03 (+0.94%)

After-hours: Sep 21, 2026, 7:56 PM ET

Overview Rating Statistics Financials Earnings Analysts Ownership Profile

Income Statement Balance Sheet Cashflow Statement Ratios

Annual Quarterly TTM

Fiscal Year Period Ending	FY 2025 Dec 30, 2025	FY 2024 Dec 30, 2024	FY 2023 Dec 30, 2023	FY 2022 Dec 30, 2022	FY 2021 Dec 30, 2021	FY 2020 Dec 30, 2020
Net Income	-201.14M	-195.88M	-198.13M	-121.82M	-165.37M	-3.41M
Depreciation & Amortization	5.38M	6.13M	4.65M	2.22M	568K	43K
Stock-Based Compensation	29.27M	26.07M	13.91M	6.46M	1.75M	391K
Other Working Capital	-6.34M	36.33M	-6.49M	-37.86M	29.99M	-86K
Other Non-Cash Items	9.27M	9.75M	11.79M	17.68M	98.42M	-4.6M
Deferred Income Tax	n/a	n/a	-279K	-964K	-624K	1.87M
Change in Working Capital	-5.34M	31.08M	2.65M	-35.4M	31.18M	164K
Operating Cash Flow	-162.56M	-122.87M	-165.41M	-131.83M	-34.08M	-5.54M
Capital Expenditures	-4.53M	-7.29M	-8.72M	-16.1M	-4.15M	-639K
Cash Acquisitions	n/a	n/a	n/a	n/a	n/a	n/a
Purchase of Investments	-205.41M	-129.45M	-104.95M	-123.34M	-81.98M	n/a
Sales Maturities Of Investments	101.18M	204.2M	132.56M	93M	13M	n/a
Other Investing Acitivies	n/a	1M	-170K	-665K	-496K	-423K
Investing Cash Flow	-108.76M	68.46M	18.71M	-47.1M	-73.63M	-1.06M
Debt Repayment	n/a	n/a	n/a	n/a	n/a	n/a
Common Stock Repurchased	n/a	n/a	n/a	n/a	n/a	n/a
Dividend Paid	n/a	n/a	n/a	n/a	n/a	n/a
Other Financial Acitivies	12M	25.74M	n/a	-3.82M	-1.09M	-20K
Financial Cash Flow	151.51M	195.88M	655K	181.49M	269.28M	34.93M
Net Cash Flow	-119.82M	141.47M	-146.05M	2.57M	161.57M	28.33M
Free Cash Flow	-167.1M	-130.16M	-174.14M	-147.92M	-38.23M	-6.18M
Adj. Free Cash Flow	-196.36M	-156.23M	-188.05M	-154.38M	-39.98M	-6.57M
Maintenance CapEx	n/a	n/a	-8.72M	-16.1M	-4.15M	-42.98K
Growth CapEx	-4.53M	-7.29M	n/a	n/a	n/a	-596.02K
Owner Earnings	-162.56M	-122.87M	-174.14M	-147.92M	-38.23M	-5.59M